Parent-reported cognitive function is associated with leukoencephalopathy in children with brain tumors

Jin-Shei Lai1, Corey Bregman2, Frank Zelko3

  • 1Medical Social Sciences and Pediatrics, Feinberg School of Medicine at Northwestern University, 633 N St Clair, #19-039, Chicago, IL, 60611, USA. js-lai@northwestern.edu.

Insights

The pediatric perceived cognitive function item bank (pedsPCF) effectively screens for cognitive dysfunction in children with brain tumors. This tool can identify cerebral compromise by correlating with MRI-based leukoencephalopathy grades, aiding early intervention.

Area of Science:

  • Pediatric Neuro-oncology
  • Neuropsychology
  • Medical Imaging

Background:

  • Cognitive dysfunction is a significant challenge for pediatric brain tumor patients.
  • Early detection and intervention are crucial for improving outcomes.
  • A user-friendly screening tool is needed to identify children requiring comprehensive neuropsychological assessment.

Purpose of the Study:

  • To evaluate the pediatric perceived cognitive function item bank (pedsPCF) as a valid indicator of cerebral compromise in children with brain tumors.
  • To determine if pedsPCF scores correlate with structural brain changes, specifically leukoencephalopathy grades on MRI.

Main Methods:

  • Data from 99 children with brain tumors and their parents were analyzed.
  • Leukoencephalopathy grade was assessed using MRI, evaluating white matter damage and deep white matter volume loss (range 0-4).
  • Parents completed the pedsPCF, with scores standardized to a US general population T-score metric (mean=50, SD=10).

Main Results:

  • The pedsPCF scores significantly differentiated between patients with varying leukoencephalopathy grades (F=4.14, p=0.0084).
  • Effect sizes for discrimination ranged from 0.09 (grade 0 vs. 1) to 1.22 (grade 0 vs. 3/4).
  • The mean pedsPCF T-score was 48.3 (SD=8.3), indicating overall performance relative to the general population.

Conclusions:

  • The pedsPCF demonstrates validity as an indicator of leukoencephalopathy in pediatric brain tumor patients.
  • Findings support the use of pedsPCF as a brief, user-friendly screening tool for neurocognitive deficits.
  • This tool can facilitate timely referrals for comprehensive neurocognitive evaluations and early intervention strategies.
Abstract